IL-32 is known to be upregulated in multiple inflammatory conditions associated with increased risk for the development of cardiovascular diseases, such with chronic viral and bacterial infections, inflammatory bowel disease and chronic obstructive pulmonary disease [40,41,42,43]. Here, IL32 is linked to inflammatory bowel disease.